Shares of Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.99% shed 6.45% to $171.14 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +1.30% falling 1.19% to 12,493.93 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.20% falling 0.18% to 32,774.41. This was the stock's third consecutive day of losses. Moderna Inc. closed $326.35 short of its 52-week high ($497.49), which the company achieved on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +1.49% fell 0.06% to $140.25, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.68% rose 0.43% to $248.36, and AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +2.39% rose 1.18% to $65.89. Trading volume (5.1 M) remained 187,742 below its 50-day average volume of 5.3 M.